# SIM2

## Overview
The SIM2 gene encodes the SIM bHLH transcription factor 2, a member of the basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) family of transcription factors. This protein is characterized by its involvement in transcriptional regulation, primarily acting as a transcriptional repressor, although it can also function as an activator in specific contexts. The SIM2 protein is integral to various developmental processes, including neurogenesis, angiogenesis, and tracheal formation, and is expressed in multiple tissues such as the brain, kidneys, and skeletal muscle. Its role in transcriptional regulation is mediated through interactions with other proteins, such as the aryl hydrocarbon receptor nuclear translocator (ARNT), which facilitates its binding to DNA and modulation of gene expression. Clinically, SIM2 is implicated in Down syndrome due to its overexpression in trisomy 21, contributing to cognitive impairments, and is also associated with various cancers, where it may influence tumorigenesis and tumor suppression (Letourneau2015HSA21; Chrast1997Cloning; Woods2008The).

## Structure
The SIM2 protein is characterized by several conserved domains typical of transcription factors, including the basic helix-loop-helix (bHLH) domain, PAS1, PAS2, and HST domains, which are crucial for dimerization and DNA binding (Chrast1997Cloning). The bHLH domain facilitates DNA binding and dimerization, while the PAS domains are involved in protein-protein interactions (Moffett1997The). The SIM2 protein also contains regions rich in serine/threonine, proline/serine, and proline/alanine, which are common in transcription repressors and activators (Chrast1997Cloning).

The protein exists in two isoforms: a long form with 667 amino acids and a short form (SIM2s) with 570 amino acids. Both forms share the same conserved domains but diverge at a specific point (Chrast1997Cloning). The SIM2 protein is predicted to have a molecular mass of 74 kD (Chrast1997Cloning). Post-translational modifications such as phosphorylation may occur, affecting its function and interactions (Moffett1997The). The structural features of SIM2, including its conserved domains, suggest a role in transcriptional regulation, potentially as a repressor (Chrast1997Cloning).

## Function
The SIM2 gene encodes a transcription factor that is part of the basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) family, which plays a significant role in transcriptional regulation. SIM2 is primarily involved in developmental processes such as neurogenesis, angiogenesis, and tracheal formation. It is expressed in various tissues, including the brain, kidneys, skeletal muscle, and craniofacial structures, with the highest expression levels observed in the kidneys, skeletal muscle, and brain (Woods2008The).

SIM2 functions as a transcriptional regulator by forming heterodimers with ARNT proteins, which allows it to bind to specific DNA sequences and regulate gene expression. Although SIM2 is generally considered a transcriptional repressor, it can also act as an activator in certain contexts. For instance, SIM2, in conjunction with ARNT1, can activate the transcription of the Myomesin2 (Myom2) gene in muscle tissue through a non-canonical E-box sequence in the Myom2 promoter (Woods2008The). This dual role highlights the context-dependent nature of SIM2's function, where it can either repress or activate transcription based on the cellular environment and promoter architecture (Woods2008The).

## Clinical Significance
The SIM2 gene, located on chromosome 21, is implicated in several clinical conditions, particularly Down syndrome (DS) and certain cancers. In DS, which results from trisomy of chromosome 21, SIM2 is overexpressed and is thought to contribute to cognitive impairments and other phenotypes associated with the condition. Studies have shown that SIM2 may play a role in neurogenesis and cognitive functions, with its overexpression linked to learning and memory deficits in animal models (Meng2006Effects; Letourneau2015HSA21).

SIM2 is also associated with various malignancies. It is upregulated in colon, prostate, and pancreatic tumors, suggesting a role in tumorigenesis. The gene's overexpression may alter the expression of downstream target genes, contributing to cancer development (Chatterjee2013Potential; Woods2008The). Additionally, SIM2 has been proposed as a potential breast tumor suppressor, with its expression levels varying between normal and cancerous tissues (Chatterjee2013Potential).

The gene's involvement in these conditions is linked to its function as a transcriptional regulator, affecting pathways related to neurodevelopment and carcinogenesis. Understanding SIM2's regulatory mechanisms is crucial for elucidating its role in these diseases (Letourneau2015HSA21).

## Interactions
SIM2, a member of the basic helix-loop-helix (bHLH) PAS family, is involved in various protein interactions that influence its role in transcriptional regulation. SIM2 interacts with the aryl hydrocarbon receptor nuclear translocator (ARNT) protein, forming complexes that are crucial for its transcriptional repression capabilities. This interaction requires the HLH and PAS domains of both SIM2 and ARNT, and it is essential for SIM2's ability to repress ARNT-mediated transactivation (Moffett1997The).

In the context of Down syndrome, SIM2 interacts with the mitotic arrest-deficient protein MAD2B. This interaction is significant in the nervous system, affecting neuron survival, axon growth, and synapse development. The interaction between SIM2 and MAD2B was confirmed through co-immunoprecipitation in rat cortex, and it may impair synaptic plasticity, affecting learning and memory in Down syndrome (Meng2012A).

In breast cancer, the SIM2s isoform interacts with the NFκB signaling pathway, where it downregulates NFκB activity by inhibiting the transcriptional activity of the NFκB/p65 complex. This interaction also affects the expression of COX-2, a key player in cancer cell invasion, suggesting a role for SIM2s in modulating inflammatory responses and tumor progression (Wyatt2019Crosstalk).


## References


[1. (Letourneau2015HSA21) Audrey Letourneau, Gilda Cobellis, Alexandre Fort, Federico Santoni, Marco Garieri, Emilie Falconnet, Pascale Ribaux, Anne Vannier, Michel Guipponi, Piero Carninci, Christelle Borel, and Stylianos E. Antonarakis. Hsa21 single-minded 2 (sim2) binding sites co-localize with super-enhancers and pioneer transcription factors in pluripotent mouse es cells. PLOS ONE, 10(5):e0126475, May 2015. URL: http://dx.doi.org/10.1371/journal.pone.0126475, doi:10.1371/journal.pone.0126475. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0126475)

[2. (Chatterjee2013Potential) Arpita Chatterjee, Samikshan Dutta, Sanjit Mukherjee, Nupur Mukherjee, Avirup Dutta, Ashis Mukherjee, Swagata Sinha, Chinmay Kumar Panda, Keya Chaudhuri, Ananda L Roy, and Kanchan Mukhopadhyay. Potential contribution of sim2 and ets2 functional polymorphisms in down syndrome associated malignancies. BMC Medical Genetics, January 2013. URL: http://dx.doi.org/10.1186/1471-2350-14-12, doi:10.1186/1471-2350-14-12. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2350-14-12)

[3. (Wyatt2019Crosstalk) Garhett L. Wyatt, Lyndsey S. Crump, Chloe M. Young, Veronica M. Wessells, Cole M. McQueen, Steven W. Wall, Tanya L. Gustafson, Yang-Yi Fan, Robert S. Chapkin, Weston W. Porter, and Traci R. Lyons. Cross-talk between sim2s and nfκb regulates cyclooxygenase 2 expression in breast cancer. Breast Cancer Research, November 2019. URL: http://dx.doi.org/10.1186/s13058-019-1224-y, doi:10.1186/s13058-019-1224-y. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s13058-019-1224-y)

[4. (Meng2006Effects) Xianfang Meng, Bin Peng, Jing Shi, Yao Zheng, Hao Chen, Jing Zhang, Lingli Li, and Chun Zhang. Effects of overexpression of sim2 on spatial memory and expression of synapsin i in rat hippocampus. Cell Biology International, 30(10):841–847, October 2006. URL: http://dx.doi.org/10.1016/j.cellbi.2006.07.003, doi:10.1016/j.cellbi.2006.07.003. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellbi.2006.07.003)

[5. (Chrast1997Cloning) Roman Chrast, Hamish S. Scott, Haiming Chen, Jun Kudoh, Colette Rossier, Shinsei Minoshima, Yimin Wang, Nobuyoshi Shimizu, and Stylianos E. Antonarakis. Cloning of two human homologs of the drosophila single-minded gene sim1 on chromosome 6q and sim2 on 21q within the down syndrome chromosomal region. Genome Research, 7(6):615–624, June 1997. URL: http://dx.doi.org/10.1101/GR.7.6.615, doi:10.1101/gr.7.6.615. This article has 88 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1101/GR.7.6.615)

[6. (Moffett1997The) Peter Moffett, Mark Reece, and Jerry Pelletier. The murine sim-2 gene product inhibits transcription by active repression and functional interference. Molecular and Cellular Biology, 17(9):4933–4947, September 1997. URL: http://dx.doi.org/10.1128/mcb.17.9.4933, doi:10.1128/mcb.17.9.4933. This article has 76 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.9.4933)

[7. (Meng2012A) Xianfang Meng, Xiujuan Tian, Xiaolan Wang, Pan Gao, and Chun Zhang. A novel binding protein of single-minded 2: the mitotic arrest-deficient protein mad2b. neurogenetics, 13(3):251–260, June 2012. URL: http://dx.doi.org/10.1007/s10048-012-0333-x, doi:10.1007/s10048-012-0333-x. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-012-0333-x)

[8. (Woods2008The) Susan Woods, Alexandra Farrall, Carl Procko, and Murray L. Whitelaw. The bhlh/per-arnt-sim transcription factor sim2 regulates muscle transcript myomesin2 via a novel, non-canonical e-box sequence. Nucleic Acids Research, 36(11):3716–3727, May 2008. URL: http://dx.doi.org/10.1093/nar/gkn247, doi:10.1093/nar/gkn247. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkn247)